Related Experiment Videos
[Iatrogenic Cushing's syndrome in a patient with complex angiomatosis. Description of a case]
Insights
Steroid therapy for severe hemangiomas can cause Cushing's syndrome. This highlights the complex treatment challenges and the necessity of multidisciplinary team management for these vascular anomalies.
Area of Science:
- Vascular Anomalies
- Pediatric Endocrinology
- Dermatology
Background:
- Hemangiomas pose significant therapeutic challenges due to potential complications from various treatment modalities.
- Effective management requires careful consideration of risks versus benefits for each patient.
Observation:
- A case of Cushing's syndrome developed in a patient undergoing steroid therapy for extensive capillary-cavernous hemangiomas.
- This adverse effect underscores the systemic impact of treatments for benign vascular tumors.
Findings:
- Systemic corticosteroid administration for hemangioma treatment can lead to significant endocrine complications, such as Cushing's syndrome.
- The study highlights the dose- and duration-dependent risks associated with steroid therapy in managing complex hemangiomas.
Implications:
- Physicians must be vigilant for endocrine side effects when using steroids for hemangioma treatment.
- Integrated, multidisciplinary team approaches are crucial for optimizing hemangioma management and mitigating treatment-related morbidity.
Abstract:
Hemangiomas present to physicians with some of the most difficult treatment problems known to medicine. Many modalities are available but all suffer some degree of complications. The Authors describe a case of Cushing's syndrome after steroid therapy of serious capillary-cavernous hemangiomas. This experience points out treatment problems and need of team management.